Series A

Gaxos.ai secures a deal with ByteDance's BytePlus, gaining access to elite AI video models to challenge giants in the booming creator content market.

Amidst a volatile stock history, GT Biopharma aims to secure vital funding for its innovative NK cell therapy pipeline at a key Toronto conference.

Tech titans like Micron, NVIDIA, and Applied Materials join forces in a $2.5B alliance to forge India into a global deep tech powerhouse.

With its expansion to Europe and LATAM, Halper AI and its founder are betting on a radical idea: the best AI is the one you never have to open.

Iterum Therapeutics secures key Medicare access for its antibiotic ORLYNVAH™, but a costly FDA trial requirement for a new use casts a shadow on its future.

A Taiwanese whisky distributor is betting big on AI with $120M in proposed deals, raising questions of genius, risk, and the frenzy of the AI gold rush.

A new 68-unit affordable senior community in Castle Hayne is secured by a key federal loan, highlighting a successful model for rural housing needs.

With its first dedicated private credit fund, Brigade Capital is targeting a complex, underserved market segment to deliver what larger lenders often miss.

Blue Cross and MassChallenge award five startups $50k each to solve critical health disparities, from endometriosis diagnosis to language access in hospitals.

YBI's new 'Landing Zone' program offers a free, equity-free path for manufacturing startups, leveraging world-class expertise to enter the US market.

A new report shows the carbon removal market has the tools to fight climate change, but widespread corporate inaction threatens to strand vital projects.

Fintech leader Saphyre appoints Damian Handzy as COO, signaling a major push to scale its AI-driven platform amid the industry’s shift to faster T+1 settlement.

With a new flexible, founder-first model, Activation Capital's Frontier BioHealth program aims to bridge the commercialization gap for life sciences startups.

Custom rug brand Ernesta opens its first Texas showroom, betting on Dallas's design scene while its model faces praise for innovation and scrutiny over quality.

Delonix Bioworks' next-gen meningitis B vaccine, DX-104, is cleared for human trials in China and Australia, aiming to challenge the market leaders.

Sun Life and DentaQuest open nominations for their Health Access Hero Awards, offering grants to groups fighting critical health disparities.

The frozen potato giant appoints an AB InBev veteran as Executive Chair and a new CFO, signaling a major push for global expansion and shareholder value.

Bermuda insurer Relm adds C-suite leaders from AXIS and Zurich, signaling a strategic push to dominate insurance for AI, crypto, and space tech.

A new AI platform is bringing Pentagon-style wargaming to the boardroom, simulating competitive futures to help companies out-maneuver rivals.

Edtech leader Echo360 targets systemic funding inequities by doubling its grant awards for underserved institutions, fueling AI-powered learning innovation.